bioAffinity Technologies, Inc. (BIAF)
Official siteHEALTHCARE • DIAGNOSTICS & RESEARCH • NASDAQ
Market Cap: $4.00M
Last updated: Nov 17, 2026 at 11:04 AM ET
bioAffinity Technologies, Inc. (BIAF) Competitors
The companies most similar to bioAffinity Technologies are iSpecimen (ISPC), MDxHealth SA (MDXH) and Bioatla (BCAB). By market cap, bioAffinity Technologies ranks 7th of the 13 companies on this page; MDxHealth SA (MDXH) is the largest at $13.75M.
Peer Comparison
BIAF's ROIC of -376.1% is below the peer median of -14.3%, and its revenue growth of -26.0% is below the median of -6.3%. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| bioAffinity Technologies (BIAF) | $4.00M | N/A | 0.3x | -278.9% | -376.1% | -26.0% | 0.00% |
| iSpecimen Inc (ISPC) | $1.66M | N/A | 1.8x | 0.0% | N/A | -78.7% | 0.00% |
| MDxHealth SA (MDXH) | $13.75M | N/A | N/A | -38.3% | -40.5% | -17.2% | 0.00% |
| Bioatla Inc (BCAB) | $2.89M | N/A | N/A | 0.0% | N/A | 31.6% | 0.00% |
| XWELL Inc. (XWEL) | $5.62M | N/A | 0.2x | -82.9% | N/A | -7.1% | 0.00% |
| Trinity Biotech plc (TRIB) | $4.96M | N/A | N/A | -85.4% | -14.3% | -5.5% | 0.00% |
| PharmaCyte Biotech Inc (PMCB) | $3.77M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Ernexa Therapeutics Inc. (ERNA) | $2.84M | N/A | N/A | 0.0% | N/A | -94.1% | 0.00% |
| Azitra Inc (AZTR) | $3.69M | N/A | N/A | 0.0% | N/A | -100.0% | 0.00% |
| Creative Medical Technology Holdings Inc (CELZ) | $4.01M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| XTL Biopharmaceuticals Ltd ADR (XTLB) | $3.93M | N/A | 4.0x | 0.0% | N/A | 0.0% | 0.00% |
| Senti Biosciences Inc (SNTI) | $5.38M | N/A | 57.2x | 0.0% | 1039.8% | -100.0% | 0.00% |
| Intelligent Bio Solutions Inc. (INBS) | $5.84M | N/A | 1.0x | -269.3% | N/A | 25.2% | 0.00% |
| Peer median | $3.97M | N/A | 1.8x | 0.0% | -14.3% | -6.3% | 0.00% |
Similar Companies
These are the 12 companies most similar to bioAffinity Technologies, ranked by how closely their business, size, sector and industry match. The largest group, 7 of the 12, is in Biotechnology; the other 5 span 2 industries.
| Company | About | Peers |
|---|---|---|
| iSpecimen Inc (ISPC)Diagnostics & Research | iSpecimen, Inc. provides technology that connects life science researchers in need of human biofluids... | ISPC competitors |
| MDxHealth SA (MDXH)Diagnostics & Research | MDxHealth SA is a prominent biotechnology company focused on precision diagnostics that enhance cancer management, particularly in prostate and bladder cancers. | MDXH competitors |
| Bioatla Inc (BCAB)Biotechnology | BioAtla, Inc., a biopharmaceutical company, develops specific and selective antibody-based therapies for the treatment of various cancers. | BCAB competitors |
| XWELL Inc. (XWEL)Diagnostics & Research | XWELL Inc., a health and wellness services company, provides spa services at airports. The company is headquartered in New York, New York. | XWEL competitors |
| Trinity Biotech plc (TRIB)Medical Devices | Trinity Biotech plc acquires, develops, manufactures and markets medical diagnostic products for the clinical laboratory and point of care (POC) segments... | TRIB competitors |
| PharmaCyte Biotech Inc (PMCB)Biotechnology | PharmaCyte Biotech, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cell therapies for cancer and diabetes in the United... | PMCB competitors |
| Ernexa Therapeutics Inc. (ERNA)Biotechnology | Brooklyn ImmunoTherapeutics, Inc., a clinical-stage biopharmaceutical company, is dedicated to developing therapies to treat cancer patients. | ERNA competitors |
| Azitra Inc (AZTR)Biotechnology | Azitra Inc, a pre-clinical biopharmaceutical company, focuses on developing therapies for precision dermatology using engineered proteins and live... | AZTR competitors |
| Creative Medical Technology Holdings Inc (CELZ)Biotechnology | Creative Medical Technology Holdings, Inc., a biotechnology company, focuses on immunology, urology, orthopedics... | CELZ competitors |
| XTL Biopharmaceuticals Ltd ADR (XTLB)Biotechnology | XTL Biopharmaceuticals Ltd., a biopharmaceutical company, is engaged in the acquisition and development of pharmaceutical products for the treatment... | |
| Senti Biosciences Inc (SNTI)Biotechnology | Senti Biosciences Inc (SNTI) is a leading biotechnology firm specializing in synthetic biology... | SNTI competitors |
| Intelligent Bio Solutions Inc. (INBS)Medical Devices | Intelligent Bio Solutions Inc. (INBS) is a pioneering biotechnology company focused on delivering cutting-edge diagnostic solutions and biomarker-driven... | INBS competitors |
Frequently Asked Questions About BIAF
Who are bioAffinity Technologies' main competitors?
The companies most similar to bioAffinity Technologies include iSpecimen (ISPC), MDxHealth SA (MDXH), Bioatla (BCAB), XWELL (XWEL) and Trinity Biotech (TRIB), listed from the closest match.
Who is bioAffinity Technologies' biggest competitor?
MDxHealth SA (MDXH) is the largest of the similar companies at $13.75M; iSpecimen (ISPC) is the closest match by business profile, size, sector and industry.
How does BIAF stock compare with its competitors?
BIAF's P/S is 0.3x against a peer median of 1.8x; its net margin is -278.9% against a peer median of 0.0%.
Which of bioAffinity Technologies' competitors pays a higher dividend?
bioAffinity Technologies pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.
Is bioAffinity Technologies bigger than its competitors?
No. bioAffinity Technologies is 7th by market cap among the 13 companies on this page; the largest is MDxHealth SA (MDXH) at $13.75M.
BIAF pages: Overview, Earnings, Financials, Competitors